Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FERMENTA BIOTECH LIMITED Board/Management Information 2019

Dec 17, 2019

60716_rns_2019-12-17_5d445334-44b6-47c1-bd4c-26dd2289f286.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [426 x 66] intentionally omitted <==

Ref: F.No.:49

December 17, 2019

Corporate Relations BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001

Dear Sir,

Sub: Notice of Board Meeting and closure of Trading Window Ref: Scrip Code: 506414

Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, December 24, 2019 , inter alia:

  • (a) to consider, approve and adopt Trust Deed of ‘Fermenta Biotech Limited ESOP Trust’, ‘Fermenta Biotech Limited- Employee Stock Option Plan 2019’ and all other relevant documents thereto by modifying the same in view of the order for Scheme of Amalgamation dated September 19, 2019 issued by the National Company Law Tribunal, Mumbai;

  • (b) to consider, approve and adopt amendment to Fermenta Biotech Limited- Employee Stock Option Plan 2019, subject to members’ approval; and

  • (c) to consider and recommend the issue of bonus equity shares to the members of the Company.

In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the “Trading Window" (period for trading in Company’s securities) has been closed with effect from December 17, 2019 and shall continue to remain closed till 48 hours after the publication of the outcome of the Board Meeting. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company’s Equity Shares, either in their own name or in the name of their immediate relatives.

Terms not defined in this notice shall have the same meaning as defined in the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders.

==> picture [426 x 66] intentionally omitted <==

==> picture [426 x 66] intentionally omitted <==

This is for your information and record.

Thanking you,

Yours faithfully,

For Fermenta Biotech Limited (Formerly known as DIL Limited)

Digitally signed by SRIKANT NATH SHARMA SRIKANT NATH DN: c=IN, o=Personal, postalCode=400610, st=Maharashtra, 2.5.4.20=2ab07dc675b7405348b9f50416c712c738a3c6f165ca 6b8e70474cfdc158e5cb, serialNumber=c7cd7ec99adaae2c3bd286ac4378ffadd7148c2 7ff6647d896904fb3e2d0942e, cn=SRIKANT NATH SHARMA SHARMA Date: 2019.12.17 12:59:59 +05'30' Srikant Sharma Company Secretary & Vice President (Legal) Membership No. FCS3617

==> picture [426 x 66] intentionally omitted <==